1.
Lebwohl M, Bukhalo M, Gold LS, Pelle M, Glick B, Llamas-Velasco M, Sanchez-Rivera S, Zhan T, Drogaris L, Douglas K, St. John G, Espaillat R, Bissonnette R. A Phase 3b Study Evaluating Safety and Efficacy of Risankizumab in Adult Patients with Moderate-to-Severe Plaque Psoriasis with Palmoplantar (Non-Pustular) Involvement. J of Skin [Internet]. 2023 Nov. 13 [cited 2024 Jul. 3];7(6):s256. Available from: https://jofskin.org/33014/index.php/skin/article/view/2429